News
-
-
PRESS RELEASE
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
ONWARD Medical N.V. announces groundbreaking advancements in blood pressure regulation after Spinal Cord Injury with ARC-IM Therapy, supported by clinical evidence in Nature and Nature Medicine -
-
PRESS RELEASE
Finnish-born FinTech Multitude AG Celebrates 20 Years of Growth and 10 Years on the Frankfurt Stock Exchange
Multitude AG, a European FinTech company, celebrates its 20th anniversary with customers, partners, and employees in Finland. Operating in 17 countries, with revenue of EUR 263.7 million in 2024 -
-
PRESS RELEASE
DEAG: Subscription period for new Corporate Bond 2025/2029 begins today – “Entertainment with yield”
DEAG begins subscription period for new Corporate Bond 2025/2029, offering a fixed interest rate of 7.00% - 8.00% p.a. Investors can subscribe through DirectPlace until 8 October 2025. Use of proceeds for refinancing and growth -
PRESS RELEASE
FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3
Curatis Holding AG receives positive outcome confirmation from FDA meeting regarding corticorelin's Phase 3 development plan for patients with PTBE secondary to solid tumor brain metastases -
-
-
